ArticleFrontiers in endocrinology2022

Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer.

Vasileios Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.